Trial Profile
A Double-Blind, Randomised, Placebo-Controlled Study to Evaluate the Photoprotective Effect of a Sustained Release dose of Melanotan in Fair skinned Healthy Caucasians
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2021
Price :
$35
*
At a glance
- Drugs Afamelanotide (Primary)
- Indications Sunburn
- Focus Therapeutic Use
- Acronyms EP008
- Sponsors Clinuvel Pharmaceuticals
- 29 Jun 2016 New trial record